Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety

R Zhu, H Liu, C Liu, L Wang, R Ma, B Chen, L Li… - Pharmacological …, 2017 - Elsevier
Cinnamaldehyde, one of the active components derived from Cinnamon, has been used as
a natural flavorant and fragrance agent in kitchen and industry. Emerging studies have been …

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

J Tomé-Carneiro, M Larrosa… - Current …, 2013 - benthamdirect.com
Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene) is a non-flavonoid polyphenol that may be
present in a limited number of foodstuffs such as grapes and red wine. Resveratrol has been …

The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications

M Teimouri, H Hosseini, Z ArabSadeghabadi… - Journal of physiology …, 2022 - Springer
Insulin resistance, the most important characteristic of the type 2 diabetes mellitus (T2DM), is
mostly caused by impairment in the insulin receptor (IR) signal transduction pathway …

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

O Vang, N Ahmad, CA Baile, JA Baur, K Brown… - PloS one, 2011 - journals.plos.org
Background Resveratrol is a natural compound suggested to have beneficial health effects.
However, people are consuming resveratrol for this reason without having the adequate …

Coumarins as potential antidiabetic agents

H Li, Y Yao, L Li - Journal of Pharmacy and Pharmacology, 2017 - academic.oup.com
Objectives Even with great advances in modern medicine and therapeutic agent
development, the search for effective antidiabetic drugs remains challenging. Coumarins are …

Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time

C Sellmann, J Priebs, M Landmann, C Degen… - The Journal of nutritional …, 2015 - Elsevier
General overnutrition but also a diet rich in certain macronutrients, age, insulin resistance
and an impaired intestinal barrier function may be critical factors in the development of …

Connecting Alzheimer's disease to diabetes: underlying mechanisms and potential therapeutic targets

MNN Vieira, RAS Lima-Filho, FG De Felice - Neuropharmacology, 2018 - Elsevier
Alzheimer's disease (AD) is a risk factor for type 2 diabetes and vice versa, and a growing
body of evidence indicates that these diseases are connected both at epidemiological …

[HTML][HTML] The role of protein tyrosine phosphatase (PTP)-1B in cardiovascular disease and its interplay with insulin resistance

SS Abdelsalam, HM Korashy, A Zeidan, A Agouni - Biomolecules, 2019 - mdpi.com
Endothelial dysfunction is a key feature of cardiovascular disorders associated with obesity
and diabetes. Several studies identified protein tyrosine phosphatase (PTP)-1B, a member …

PTP1B and TCPTP–nonredundant phosphatases in insulin signaling and glucose homeostasis

T Tiganis - The FEBS journal, 2013 - Wiley Online Library
Insulin resistance is a key pathological feature of type 2 diabetes and is characterized by
defects in signaling by the insulin receptor (IR) protein tyrosine kinase. The inhibition of …

Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer's therapy?

MNN Vieira, NM Lyra e Silva, ST Ferreira… - Frontiers in aging …, 2017 - frontiersin.org
Despite significant advances in current understanding of mechanisms of pathogenesis in
Alzheimer's disease (AD), attempts at drug development based on those discoveries have …